30 related articles for article (PubMed ID: 38557820)
1. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
2. Supplementation of High-Strength Oral Probiotics Improves Immune Regulation and Preserves Beta Cells among Children with New-Onset Type 1 Diabetes Mellitus: A Randomised, Double-Blind Placebo Control Trial.
Lokesh MN; Kumar R; Jacob N; Sachdeva N; Rawat A; Yadav J; Dayal D
Indian J Pediatr; 2024 Apr; ():. PubMed ID: 38557820
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
4. Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial.
Lindsay KL; Brennan L; Kennelly MA; Maguire OC; Smith T; Curran S; Coffey M; Foley ME; Hatunic M; Shanahan F; McAuliffe FM
Am J Obstet Gynecol; 2015 Apr; 212(4):496.e1-11. PubMed ID: 25687568
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
Tonucci LB; Olbrich Dos Santos KM; Licursi de Oliveira L; Rocha Ribeiro SM; Duarte Martino HS
Clin Nutr; 2017 Feb; 36(1):85-92. PubMed ID: 26732026
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of a probiotic and a prebiotic examining metabolic and mental health outcomes in adults with pre-diabetes.
Barthow C; Hood F; Crane J; Huthwaite M; Weatherall M; Parry-Strong A; Krebs J
BMJ Open; 2022 Mar; 12(3):e055214. PubMed ID: 35332040
[TBL] [Abstract][Full Text] [Related]
7. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study.
Kumar S; Kumar R; Rohilla L; Jacob N; Yadav J; Sachdeva N
Pediatr Diabetes; 2021 Nov; 22(7):1014-1022. PubMed ID: 34174128
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of
Groele L; Szajewska H; Szalecki M; Świderska J; Wysocka-Mincewicz M; Ochocińska A; Stelmaszczyk-Emmel A; Demkow U; Szypowska A
BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33771763
[TBL] [Abstract][Full Text] [Related]
9. Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine.
Bianchini S; Orabona C; Camilloni B; Berioli MG; Argentiero A; Matino D; Alunno A; Albini E; Vacca C; Pallotta MT; Mancini G; Tascini G; Toni G; Mondanelli G; Silvestri E; Grohmann U; Esposito S
Hum Vaccin Immunother; 2020; 16(1):86-94. PubMed ID: 31210557
[TBL] [Abstract][Full Text] [Related]
10. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes.
Ho J; Nicolucci AC; Virtanen H; Schick A; Meddings J; Reimer RA; Huang C
J Clin Endocrinol Metab; 2019 Oct; 104(10):4427-4440. PubMed ID: 31188437
[TBL] [Abstract][Full Text] [Related]
11. Microbiome Dependent Regulation of T
Pandiyan P; Bhaskaran N; Zou M; Schneider E; Jayaraman S; Huehn J
Front Immunol; 2019; 10():426. PubMed ID: 30906299
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders.
Pagliari D; Saviano A; Newton EE; Serricchio ML; Dal Lago AA; Gasbarrini A; Cianci R
Mediators Inflamm; 2018; 2018():7946431. PubMed ID: 29563853
[TBL] [Abstract][Full Text] [Related]
13. Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.
Li C; Zhang L; Chen Y; Lin X; Li T
Exp Ther Med; 2016 May; 11(5):1625-1632. PubMed ID: 27168782
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
